Using Visible Residue Limits for Introducing New Compounds into a Pharmaceutical Research Facility

An increasing number of new compounds are being introduced into pharmaceutical pilot plants.The knowledge base for these compounds regarding their toxicities,physical handling, and cleaning is limited.The authors examine various approaches for addressing the cleaning validation of new compounds and discuss the role of determining appropriate visible residue limits.

Related Content:

Aseptic/Sterile ProcessingBiologic DrugsProcess ValidationManufacturingQuality SystemsDosage FormsPharmaceutical Technology-04-02-2005

EC Approves Vabysmo for Two Leading Causes of Vision Loss

Congress Slated to Reauthorize User Fees Without FDA “Improvements”

The Manufacturing Edge on Path to Market